GlassScriptPhysician profile
Daryl Wayne Mckee
NPI 1013412410
$33,229.45
in general payments reported to CMS, 2019-2025
8 companies · $30K in 2025
The $30K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.64 · 2021: $387 · 2023: $601 · 2024: $1,788 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $9,138 · Consulting Fee: $5,830 · Travel and Lodging: $234 · Education: $95.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,500.00 |
| Food and Beverage | $9,138.37 |
| Consulting Fee | $5,830.00 |
| Travel and Lodging | $234.03 |
| Education | $95.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $18,962.24 | 2025 | Daxxify |
| Merz North America, INC. | $9,836.34 | 2023-2025 | Xeomin |
| Lumenis Be INC | $3,500.00 | 2025 | M22 |
| Medical Device Business Services, INC. | $367.42 | 2021 | |
| Abbvie INC. | $295.27 | 2024-2025 | |
| Galderma Laboratories, L.P. | $204.00 | 2024 | Dysport |
| Avanos Medical | $44.64 | 2019 | |
| Hologic Sales and Service, LLC | $19.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.